Exagen, Inc. (XGN)
4.98
-0.10
(-1.97%)
USD |
NASDAQ |
May 29, 16:00
4.99
+0.01
(+0.20%)
After-Hours: 20:00
Exagen Total Liabilities (Quarterly) : 37.52M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Myriad Genetics, Inc. | 336.30M |
| BioRestorative Therapies, Inc. | 1.615M |
| CareDx, Inc. | 97.53M |
| Natera, Inc. | 840.38M |
| Sera Prognostics, Inc. | 25.92M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 51.96M |
| Shareholders Equity (Quarterly) | 14.43M |
| Debt to Equity Ratio | 1.881 |
| Current Ratio | 3.469 |
| Net Debt Paydown Yield | -1.05% |